Samyang Foods (003230) Q4 2024 earnings summary

Executive summary

• Achieved record consolidated revenue of KRW 1,728 billion, up 44.9% year-over-year, driven by strong overseas sales and product portfolio expansion.

• Operating income surged 133.6% to KRW 345 billion, and net income rose 114.3% to KRW 271 billion, reflecting improved cost structure and global brand growth.

• Major investments in production capacity, including new plants in Korea and China, and expansion into new overseas markets such as Europe and Indonesia.

Financial highlights

• Revenue: KRW 1,728 billion (+44.9% YoY); Operating income: KRW 345 billion (+133.6% YoY); Net income: KRW 271 billion (+114.3% YoY).

• Gross margin improved to 41.9% from 34.9% YoY; Operating margin rose to 19.9% from 12.4%.

• Cash and cash equivalents at year-end: KRW 335 billion, up from KRW 219 billion.

• Debt ratio decreased to 92.6% from 102.9%; current ratio improved to 137.4%.

• Dividend per share increased to KRW 3,300 (including interim and final dividends).

Outlook and guidance

• Continued focus on global expansion, with new manufacturing facilities in China and Singapore planned.

• Targeting further revenue and profit growth through product innovation and overseas market penetration.

• Ongoing investments in R&D and production automation to support premium and health-oriented product lines.